Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: Pharmacodynamic considerations

Epilepsia

Volumn 43, Issue SUPPL. 2, 2002, Pages 8-13

  Torta, Riccardo ^a,c   Monaco, Francesco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Department of Neurosciences ^*  (Italy)

Author keywords

Antidepressants; Antipsychotics; Epilepsy

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4,6,6A,7,8,12B HEXAHYDRO 7 METHYLINDOLO[4,3 AB]PHENANTHRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTIDEPRESSANT AGENT; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; HISTAMINE H1 RECEPTOR; NEUROLEPTIC AGENT; NEUROSTEROID; OLANZAPINE; QUETIAPINE; QUINPIROLE; RACLOPRIDE; REMOXIPRIDE; RISPERIDONE; SEROTONIN; SEROTONIN AGONIST; SERTRALINE; SEX HORMONE; SKF 38293; ZOTEPINE;

ANTICONVULSANT ACTIVITY; COMORBIDITY; DRUG POTENCY; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; INCIDENCE; KINDLING; MENTAL DISEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; REVIEW; SEIZURE;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; EPILEPSY; HUMANS; MENTAL DISORDERS; MOOD DISORDERS;

EID: 0036124003     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.043s2008.x     Document Type: Review

References (57)

1. Psychiatric issues in epilepsy
2. Mood disturbances, psychoses and epilepsy
3. Behavioural, psychotic and anxiety disorders in epilepsy: Etiology, clinical features and therapeutical implications
4. Therapeutic aspects of depression and epilepsy: New vs old antidepressant drugs
5. Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock
6. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats
7. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide
8. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats
9. The role of dopamine in epilepsy
10. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse
11. Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis
12. Neuroleptic-induced seizures: An in vitro technique for assessing relative risk
13. Neuroleptic and antiepileptic treatment in the mentally retarded
14. Seizure risk associated with psychotropic drugs: Clinical and pharmacokinetic considerations
15. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse
16. Radioreceptor binding profile of the atypical antipsychotic olanzapine
17. Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice
18. Spontaneous EEG paroxysms in the rat: Effects of psychotropic and alpha-adrenergic agents
19. Epilepsy and hormones
20. Gli ansiolitici
21. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: Pharmacological evidence and therapeutic opportunities
22. Cocaine, kindling and psychosis
23. Lidocaine-kindled limbic seizures: Behavioural implications
24. Conditioning, sensitiziation and kindling: For the course of affective illness
25. Does kindling model anything clinically relevant?
26. Cognitive effects of vigabatrin: A review
27. Lack of association between vigabatrin and impaired cognition
28. Protective effect of clozapine against pentylenetetrazol convulsions and kindling
29. Sensitization with clozapine: Beyond the dopamine hypothesis
30. Spectrum of EEG abnormalities during clozapine treatment
31. Clozapine and seizures: A review
32. Atypical antipsychotics
33. Generalized seizures during treatment of schizophrenia with zotepine
34. Five cases of schizophrenia with convulsive seizures during zotepine administration
35. Convulsive seizures in schizophrenic patients induced by zotepine administration
36. Antagonism by olanzapine of dopamine D1, serotonin 2, muscarinic, histamine 1, and alpha 1-adrenergic receptors in vitro
37. Tran PV the comparative peripheral anticholinergic-like adverse event profiles of olanzapine and risperidone
38. Olanzapine increases allopregnanolone in the rat cerebral cortex
39. Olanzapine drug monograph
40. Interactions between anticonvulsant and psychoactive drugs
41. Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane: Pharmacological studies in rodents and baboon, Papio papio
42. Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice
43. The anticonvulsant effect of deprenyl on pentylenetetrazol-induced seizures in Lewis rats
44. Neuropsychiatric aspects of epilepsy
45. Seizures with antidepressants: An in vitro tecnique to assess relative risk
46. Seizure activity in photo-sensitive baboons following antidepressant drugs and the role of serotoninergic mechanism
47. Tricyclic antidepressant overdose: A review
48. Assessment of epileptogenic potential experimental, clinical and epidemiological approaches
49. Depression in epilepsy: Aetiology, phenomenology and treatment
50. Antidepressant and the risk of seizures
51. Anticonvulsant effect of fluoxetine in humans
52. Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy
53. Osservazioni su di un caso con inaspettato stato di male convulsivo: Ruolo della fluoxetina
54. Seizure activity associated with fluoxetine therapy
55. Seizures associated with fluoxetine therapy
56. Serotonin reuptake inhibitors, epilepsy and myoclonus
57. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy